News
ProNova Introduces the SC360u Through Strategic Partnership with Leo Cancer Care
Maryville, Tennessee, September 30, 2024 – ProNova Solutions, LLC, the only US owned and operated technology and proton therapy manufacturing company offers a new and unique proton therapy solution to address unmet market needs.
The ProNova SC360u will be enabled by strategic partner, Leo Cancer Care, innovator of the upright patient positioning and imaging in particle therapy and integrated with ProNova’s Superconducting Isochronous Cyclotron and state-of-the-art beam delivery system capable of ARC and FLASH therapy, aiming to making the SC360u a sustainable future-proof investment. The unique SC360u plans to offer various configurations of ultra-compact single-room and multi-room systems including a two-room configuration equivalent to the footprint of a two-room LINAC bunker, and the lowest cost per patient treatment.
“We embrace the innovative product launch of the SC360u that combines upright positioning systems and CT scanner technology with advanced beam delivery”, says Moataz Karmalawy, President/CEO of ProNova Solutions, “providing solutions for today and the future.”
About ProNova Solutions, LLC
ProNova is the only US owned and operated US technology and proton therapy manufacturing company, established in 2010 with a clear mission to overcome the barriers restricting access to proton therapy with core values of putting the patient first and delivering quality performance without compromise. Driven and inspired by the rewards of improved patient clinical outcomes from proton therapy treatment, ProNova’s launch of the SC360 became an industry benchmark as the first and only 360-degree compact superconducting gantry, treating patients since 2018. ProNova is a pioneer, leader, and contributor to global advancements in cancer treatment and cancer care.
Currently not FDA Approved for Clinical Use
Nancy Howard, ProNova
Solutions: Email